Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outdoor Residual Insecticide Spraying (ODRS), a New Approach for the Control of the Exophilic Vectors of Human Visceral Leishmaniasis: Phlebotomus orientalis in East Africa.
Elnaiem DA, Dakein O, Alawad AM, Alsharif B, Khogali A, Jibreel T, Osman OF, Has'san H, Atia AM, Elhag M, Den Boer M, Ritmeijer K, Bern C, Alvar J, Khalid N, Courtenay O. Elnaiem DA, et al. Among authors: ritmeijer k. PLoS Negl Trop Dis. 2020 Oct 20;14(10):e0008774. doi: 10.1371/journal.pntd.0008774. eCollection 2020 Oct. PLoS Negl Trop Dis. 2020. PMID: 33079934 Free PMC article.
Advanced HIV disease and associated attrition after re-engagement in HIV care in Myanmar from 2003 to 2019: a retrospective cohort study.
Mesic A, Homan T, Lenglet A, Thit P, Mar HT, Sabai SM, Thandar MP, Thwe TT, Kyaw AA, Decroo T, Spina A, Ariti C, Ritmeijer K, Van Olmen J, Oo HN, Lynen L. Mesic A, et al. Among authors: ritmeijer k. Int Health. 2023 Jul 4;15(4):453-461. doi: 10.1093/inthealth/ihac069. Int Health. 2023. PMID: 36318805 Free PMC article.
Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial.
Nyang'wa BT, Berry C, Kazounis E, Motta I, Parpieva N, Tigay Z, Moodliar R, Dodd M, Solodovnikova V, Liverko I, Rajaram S, Rassool M, McHugh T, Spigelman M, Moore DA, Ritmeijer K, du Cros P, Fielding K; TB-PRACTECAL team. Nyang'wa BT, et al. Among authors: ritmeijer k. Lancet Respir Med. 2024 Feb;12(2):117-128. doi: 10.1016/S2213-2600(23)00389-2. Epub 2023 Nov 16. Lancet Respir Med. 2024. PMID: 37980911 Free article. Clinical Trial.
A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis.
Nyang'wa BT, Berry C, Kazounis E, Motta I, Parpieva N, Tigay Z, Solodovnikova V, Liverko I, Moodliar R, Dodd M, Ngubane N, Rassool M, McHugh TD, Spigelman M, Moore DAJ, Ritmeijer K, du Cros P, Fielding K; TB-PRACTECAL Study Collaborators. Nyang'wa BT, et al. Among authors: ritmeijer k. N Engl J Med. 2022 Dec 22;387(25):2331-2343. doi: 10.1056/NEJMoa2117166. N Engl J Med. 2022. PMID: 36546625 Clinical Trial.
Liposomal amphotericin B for the treatment of visceral leishmaniasis.
Bern C, Adler-Moore J, Berenguer J, Boelaert M, den Boer M, Davidson RN, Figueras C, Gradoni L, Kafetzis DA, Ritmeijer K, Rosenthal E, Royce C, Russo R, Sundar S, Alvar J. Bern C, et al. Among authors: ritmeijer k. Clin Infect Dis. 2006 Oct 1;43(7):917-24. doi: 10.1086/507530. Epub 2006 Aug 28. Clin Infect Dis. 2006. PMID: 16941377
Paromomycin.
Davidson RN, den Boer M, Ritmeijer K. Davidson RN, et al. Among authors: ritmeijer k. Trans R Soc Trop Med Hyg. 2009 Jul;103(7):653-60. doi: 10.1016/j.trstmh.2008.09.008. Epub 2008 Oct 23. Trans R Soc Trop Med Hyg. 2009. PMID: 18947845 Review.
Developments in the treatment of visceral leishmaniasis.
den Boer ML, Alvar J, Davidson RN, Ritmeijer K, Balasegaram M. den Boer ML, et al. Among authors: ritmeijer k. Expert Opin Emerg Drugs. 2009 Sep;14(3):395-410. doi: 10.1517/14728210903153862. Expert Opin Emerg Drugs. 2009. PMID: 19708817 Free article. Review.
97 results